Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven Inflammation

Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven Inflammation

Saved in:

Bibliographic Details
Main Authors:	Katherine A. Gosselé, Irene Latino, Eleen Laul, Mariia S. Kirillova, Vlad Pascanu, Emanuele Carloni, Rajiv K. Bedi, Chiara Pizzichetti, Amedeo Caflisch, Santiago F. González, Cristina Nevado
Format:	Article
Language:	English
Published:	American Chemical Society 2025-06-01
Series:	JACS Au
Online Access:	https://doi.org/10.1021/jacsau.5c00085
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recent Advances in CBP/EP300 Degraders
by: Leonardo Palaferri, et al.
Published: (2025-03-01)

CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells
by: Riley M. Horvath, et al.
Published: (2024-12-01)

DUX-mediated configuration of p300/CBP drives minor zygotic genome activation independent of its catalytic activity
by: Lieying Xiao, et al.
Published: (2025-04-01)

The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer
by: Yuqian Yan, et al.
Published: (2019-09-01)

A Minireview on BET Inhibitors: Beyond Bromodomain Targeting
by: Mikhail S. Iudin, et al.
Published: (2025-03-01)

A Novel EP300 Variant in an African American Girl With Global Developmental Delay and Leukemia
by: Subit Barua, et al.
Published: (2025-06-01)

Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
by: Dan Zou, et al.
Published: (2024-11-01)

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction
by: Stéphanie Verbeke, et al.
Published: (2025-02-01)

Discovery of YTHDF2 Ligands by Fragment-Based Design
by: Annalisa Invernizzi, et al.
Published: (2025-06-01)

Editorial
by: Amandine Kolleth, et al.
Published: (2025-03-01)

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
by: Wei Chen, et al.
Published: (2025-01-01)

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
by: Vivian Chua, et al.
Published: (2019-01-01)

CRISPR/Cas9 editing of CBP80 enhances drought tolerance in potato (Solanum tuberosum)
by: C. A. Decima Oneto, et al.
Published: (2025-07-01)

CITED2 Binding to EP300 Regulates Human Spermatogonial Stem Cell Proliferation and Survival Through HSPA6
by: Yongzhe Chen, et al.
Published: (2025-01-01)

Phylogenomic analysis of bromodomain genes in cotton (Gossypium spp.) and their potential roles in abiotic stress tolerance
by: Muhammad Tayyab, et al.
Published: (2025-07-01)

Correction: CRISPR/Cas9 editing of CBP80 enhances drought tolerance in potato (Solanum tuberosum)
by: C. A. Decima Oneto, et al.
Published: (2025-08-01)

EP300 Modulates MCM8 Transcription and Augments the Malignant Phenotype of Hepatitis B Virus–Positive Hepatocellular Carcinoma Cells
by: Fang Xue, et al.
Published: (2025-06-01)

Targeting EP300 in diffuse large b-cell lymphoma: efficacy of A485 and synergistic effects with XPO1 inhibition
by: Yanan Jiang, et al.
Published: (2025-05-01)

TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
by: Gang Yu, et al.
Published: (2022-01-01)

Rubinstein Taybi syndrome caused by EP300 gene mutation: what we learned from two cases and literature review
by: Yefeng Wang, et al.
Published: (2025-07-01)

P147: A novel EP300::PATZ1 fusion identified in a patient with high-grade neuroepithelial tumor
by: Konara Mudiyanselage Maduhasi Bandara, et al.
Published: (2025-01-01)

Bromodomain-containing protein 4 knockdown promotes neuronal ferroptosis in a mouse model of subarachnoid hemorrhage
by: Peng Lu, et al.
Published: (2026-02-01)

The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro
by: Marta Matuszewska, et al.
Published: (2025-04-01)

Functional characterization of the catalytic and bromodomain of FgGCN5 in development, DON production and virulence of Fusarium graminearum
by: Qian-nan WANG, et al.
Published: (2020-10-01)

Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal Potential
by: Kaiyao Wei, et al.
Published: (2025-03-01)

LncRNA EP300-AS1 interacts with PTBP1 to destabilize PRMT5 mRNA and suppresses NSCLC growth and metastasis
by: Jingyi Chen, et al.
Published: (2025-08-01)

VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300
by: Susu Guo, et al.
Published: (2025-05-01)

SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells
by: Weiwei Tao, et al.
Published: (2020-10-01)

Targeting CBP revers chemoresistance to 5‐FU of CDX2/REG4 double‐positive gastric cancer
by: Zhiyuan Fan, et al.
Published: (2024-11-01)

The histone acetyltransferase CBP participates in regulating the DNA damage response through ATM after double-strand breaks
by: Wafaa S. Ramadan, et al.
Published: (2025-04-01)

EP300-mediated H3 acetylation elevates MTHFD2 expression to reduce mitochondrial dysfunction in lipopolysaccharide-induced tubular epithelial cells
by: Weike Hu
Published: (2024-12-01)

Phosphorylation-stabilized CRTC1 cooperates with CBP and androgen receptor to transactivate AMH expression and drive polycystic ovary syndrome
by: Yunmei Ke, et al.
Published: (2025-06-01)

Cbp1, a fungal virulence factor under positive selection, forms an effector complex that drives macrophage lysis.
by: Dinara Azimova, et al.
Published: (2022-06-01)

Prolonged Response of a Patient with Relapsed Acute Myeloid Leukemia to a Novel Oral Bromodomain Extraterminal Inhibitor (BETi)
by: Meilen Chang Muñoz, et al.
Published: (2020-01-01)

A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling
by: Hyemi Lee, et al.
Published: (2025-07-01)

The Bromodomain and Extraterminal Protein Inhibitor Apabetalone Ameliorates Kidney Injury in Diabetes by Regulating Cholesterol Accumulation and Modulating the Gut Microbiota
by: Min Wang, et al.
Published: (2025-02-01)

De contención a exclusión: impactos de la derogación de CBP One en el acceso al asilo
by: Olga Odgers-Ortiz, et al.
Published: (2025-05-01)

Evaluation of Extraction Buffers for Protein Identification in Fish Paste with Chicken Blood Plasma (CBP) Spikes: A Preliminary Mass Spectrometry Study
by: Nurhazirah Azmi, et al.
Published: (2025-03-01)

Bromodomain-containing protein 4 contributes to chronic postsurgical pain via activating TLR4/NF-kappaB-dependent neuroinflammation
by: Ruichen Shu, et al.
Published: (2025-07-01)

<i>cBP-Tnet</i>: Continuous Blood Pressure Estimation Using Multi-Task Transformer Network with Automatic Photoplethysmogram Feature Extraction
by: Angelino A. Pimentel, et al.
Published: (2025-07-01)